Annual SGA
$19.06 M
+$1.50 M+8.55%
December 31, 2023
Summary
- As of February 7, 2025, LYRA annual SGA is $19.06 million, with the most recent change of +$1.50 million (+8.55%) on December 31, 2023.
- During the last 3 years, LYRA annual SGA has risen by +$9.37 million (+96.73%).
- LYRA annual SGA is now at all-time high.
Performance
LYRA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.93 M
-$1.21 M-23.51%
September 30, 2024
Summary
- As of February 7, 2025, LYRA quarterly SGA is $3.93 million, with the most recent change of -$1.21 million (-23.51%) on September 30, 2024.
- Over the past year, LYRA quarterly SGA has dropped by -$1.07 million (-21.43%).
- LYRA quarterly SGA is now -32.43% below its all-time high of $5.82 million, reached on March 31, 2024.
Performance
LYRA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.42 B
-$97.61 M-7.38%
September 30, 2024
Summary
- As of February 7, 2025, LYRA TTM SGA is -$1.42 billion, with the most recent change of -$97.61 million (-7.38%) on September 30, 2024.
- Over the past year, LYRA TTM SGA has dropped by -$1.44 billion (-7539.71%).
- LYRA TTM SGA is now -1012.20% below its all-time high of -$127.76 million.
Performance
LYRA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
LYRA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.6% | -21.4% | -7539.7% |
| 3 y3 years | +96.7% | -21.4% | -7539.7% |
| 5 y5 years | +440.2% | -21.4% | -7539.7% |
LYRA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.1% | -32.4% | +10.2% | -103.1% | at low |
| 5 y | 5-year | at high | +324.7% | -32.4% | +206.2% | -1012.2% | at low |
| alltime | all time | at high | +440.2% | -32.4% | +357.1% | -1012.2% | at low |
Lyra Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.93 M(-23.5%) | $19.25 M(-5.3%) |
| Jun 2024 | - | $5.14 M(-11.7%) | $20.32 M(+2.9%) |
| Mar 2024 | - | $5.82 M(+33.5%) | $19.75 M(+3.6%) |
| Dec 2023 | $19.06 M(+8.5%) | $4.36 M(-12.9%) | $19.06 M(-0.2%) |
| Sep 2023 | - | $5.00 M(+9.5%) | $19.10 M(-0.7%) |
| Jun 2023 | - | $4.57 M(-10.9%) | $19.23 M(+2.3%) |
| Mar 2023 | - | $5.13 M(+16.5%) | $18.80 M(+7.1%) |
| Dec 2022 | $17.56 M(+23.6%) | $4.40 M(-14.4%) | $17.56 M(+5.0%) |
| Sep 2022 | - | $5.14 M(+24.3%) | $16.72 M(+7.2%) |
| Jun 2022 | - | $4.13 M(+6.3%) | $15.61 M(+3.8%) |
| Mar 2022 | - | $3.89 M(+9.0%) | $15.03 M(+5.8%) |
| Dec 2021 | $14.21 M | $3.57 M(-11.2%) | $14.21 M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $4.02 M(+12.9%) | $13.95 M(+10.9%) |
| Jun 2021 | - | $3.56 M(+16.3%) | $12.58 M(+9.8%) |
| Mar 2021 | - | $3.06 M(-7.5%) | $11.46 M(+18.3%) |
| Dec 2020 | $9.69 M(+115.9%) | $3.31 M(+24.9%) | $9.69 M(+24.9%) |
| Sep 2020 | - | $2.65 M(+8.6%) | $7.75 M(+19.5%) |
| Jun 2020 | - | $2.44 M(+90.2%) | $6.49 M(+32.1%) |
| Mar 2020 | - | $1.28 M(-6.8%) | $4.91 M(+9.4%) |
| Dec 2019 | $4.49 M(+27.2%) | $1.38 M(-0.6%) | $4.49 M(+44.3%) |
| Sep 2019 | - | $1.39 M(+60.1%) | $3.11 M(+80.3%) |
| Jun 2019 | - | $865.00 K(+0.6%) | $1.73 M(+100.6%) |
| Mar 2019 | - | $860.00 K | $860.00 K |
| Dec 2018 | $3.53 M | - | - |
FAQ
- What is Lyra Therapeutics annual SGA?
- What is the all time high annual SGA for Lyra Therapeutics?
- What is Lyra Therapeutics annual SGA year-on-year change?
- What is Lyra Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly SGA year-on-year change?
- What is Lyra Therapeutics TTM SGA?
- What is the all time high TTM SGA for Lyra Therapeutics?
- What is Lyra Therapeutics TTM SGA year-on-year change?
What is Lyra Therapeutics annual SGA?
The current annual SGA of LYRA is $19.06 M
What is the all time high annual SGA for Lyra Therapeutics?
Lyra Therapeutics all-time high annual SGA is $19.06 M
What is Lyra Therapeutics annual SGA year-on-year change?
Over the past year, LYRA annual SGA has changed by +$1.50 M (+8.55%)
What is Lyra Therapeutics quarterly SGA?
The current quarterly SGA of LYRA is $3.93 M
What is the all time high quarterly SGA for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly SGA is $5.82 M
What is Lyra Therapeutics quarterly SGA year-on-year change?
Over the past year, LYRA quarterly SGA has changed by -$1.07 M (-21.43%)
What is Lyra Therapeutics TTM SGA?
The current TTM SGA of LYRA is -$1.42 B
What is the all time high TTM SGA for Lyra Therapeutics?
Lyra Therapeutics all-time high TTM SGA is -$127.76 M
What is Lyra Therapeutics TTM SGA year-on-year change?
Over the past year, LYRA TTM SGA has changed by -$1.44 B (-7539.71%)